Schedule 13G ownership disclosure

Nurix Therapeutics Inc

Common stock, par value $0.001 per share · CUSIP: 67080M103

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Deep Track Capital, LP

    Shares: 3,000,000.00 · Class: 4.24%

  • Deep Track Biotechnology Master Fund, Ltd.

    Shares: 3,000,000.00 · Class: 4.24%

  • David Kroin

    Shares: 3,000,000.00 · Class: 4.24%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-25-000876
Form type
SCHEDULE 13G/A
Filer
Deep Track Capital, LP
CIK
CIK 1856083
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub